Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
Tumor recurrence after surgical resection is associated with a poor clinical outcome. Here the authors design a manganese dioxide-based nanosystem to increase response to radio-immunotherapy by relieving tumor hypoxia and targeting myeloid cells, showing reduced post-surgical cancer recurrence and m...
Main Authors: | Xin Guan, Liping Sun, Yuting Shen, Fengshan Jin, Xiaowan Bo, Chunyan Zhu, Xiaoxia Han, Xiaolong Li, Yu Chen, Huixiong Xu, Wenwen Yue |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-30543-w |
Similar Items
-
PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
by: Peng Liu, et al.
Published: (2022-12-01) -
PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
by: Dushek, O, et al.
Published: (2016) -
CaCO3 powder-mediated biomineralization of antigen nanosponges synergize with PD-1 blockade to potentiate anti-tumor immunity
by: Runping Su, et al.
Published: (2023-04-01) -
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
by: Jeffrey Schlom, et al.
Published: (2022-06-01) -
PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer
by: Duk Ki Kim, et al.
Published: (2022-10-01)